JO
ASLN

John Overdeck’s ASLAN Pharmaceuticals Limited American Depositary Shares ASLN Stock Holding History

John Overdeck’s Portfolio ASLN Stock Details ASLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-747
Closed -$61K – 3972
2019
Q4 		$61K Buy
+747
New +$53.3K ﹤0.01% 3558

Other funds holding ASLN

Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $407M AUM 87.11% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

John Overdeck's ASLN Position: Q1 2020 in Review

John Overdeck sold out of ASLAN Pharmaceuticals Limited American Depositary Shares (ASLN) in Q1 2020, closing a stake of 747 shares — an estimated $61K sold.

John Overdeck first reported a position in ASLN in Q4 2019 and held it in 1 quarter. The position peaked at $61K in Q4 2019. 11 funds tracked by Wall St. Rank hold ASLN as of Q1 2020.

  • John Overdeck reported no remaining ASLAN Pharmaceuticals Limited American Depositary Shares position as of Q1 2020 after selling out during the quarter.
  • John Overdeck sold 747 ASLAN Pharmaceuticals Limited American Depositary Shares shares in Q1 2020, an estimated $61K.
  • John Overdeck first reported a position in ASLAN Pharmaceuticals Limited American Depositary Shares in Q4 2019 and held it in 1 quarter.
  • John Overdeck's ASLAN Pharmaceuticals Limited American Depositary Shares position peaked at $61K in Q4 2019.
  • 11 funds tracked by Wall St. Rank held ASLAN Pharmaceuticals Limited American Depositary Shares as of Q1 2020.

Based on Two Sigma Investments's 13F filing for Q1 2020, filed 15 May 2020.